171results about How to "Reduce local pressure" patented technology

Medical devices, and in particular implantable medical devices, including self-expanding stents, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment.

A semiconductor device (100) comprises a first resin substrate (101) on which a first semiconductor chip (125) is mounted a surface thereof; a second resin substrate (111) on which a second semiconductor chip (131) is mounted on a surface thereof; and a resin base material (109), joined to a front surface of the first resin substrate (101) and to a back surface of the second resin substrate (111), so that these surfaces are electrically connected. The resin base material (109) is disposed in a circumference of the first resin substrate (101) in the surface of the first resin substrate (101). Further, the first semiconductor chip (125) is disposed in a space section provided among the first resin substrate (101), the second resin substrate (111) and the resin base material (109) in the surface of the first resin substrate (101).

Methods and apparatus for connecting to a bone, which avoid the use of bone screws. A triangular shaped modular implant is used, with two sides of the structure and their respective vertex secured generally within the bone, with the base of the triangle outside the bone. These two arms, whether straight or arcuate, are cannulated, and are held together at their distal ends by a tightened cable that runs through both of the arms. The proximal ends of these arms are connected to a base side that completes the triangular structure. The device may be inserted into a vertebra and the base used for vertebral fusion. Alternatively, the arms themselves may be used to stabilize and fixate adjacent vertebrae, by insertion through adjacent vertebrae trans-segmentally. In the latter case, the vertex may be within the intervertebral space or within the vertebral body close to the intervertebral space.

A solderable device includes a substrate and a soldering pad overlying the substrate. A solder mask overlies the substrate and portions of the soldering pad. The solder mask has an opening that exposes a portion of the soldering pad. The opening has at least two edges that symmetrically overlie portions of the soldering pad.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and / or compounds may be utilized to promote healing, including the formation of blood clots. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and / or compounds from the implantable medical devices.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and / or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and / or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and / or compounds from the implantable medical devices. Liquid formulations, including solutions and suspensions of the various drugs, agents and / or compounds, may be locally or regionally delivered. In each of these instances, antioxidants are utilized to prolong product integrity.

The present invention provides a semiconductor device which is not easily damaged by external local pressure. The present invention further provides a method for manufacturing a highly-reliable semiconductor device, which is not destructed by external local pressure, with a high yield. A structure body, in which high-strength fiber of an organic compound or an inorganic compound is impregnated with an organic resin, is provided over an element layer having a semiconductor element formed using a non-single crystal semiconductor layer, and heating and pressure bonding are performed, whereby a semiconductor device is manufactured, to which the element layer and the structure body in which the high-strength fiber of an organic compound or an inorganic compound is impregnated with the organic resin are firmly fixed together.

The present invention provides a semiconductor device which is not easily damaged by external local pressure. The present invention further provides a manufacturing method of a highly-reliable semiconductor device, which is not destroyed by external local pressure, with a high yield. A structure body, in which high-strength fiber of an organic compound or an inorganic compound is impregnated with an organic resin, is provided over an element substrate having a semiconductor element formed using a single crystal semiconductor region, and heating and pressure bonding are performed, whereby a semiconductor device is manufactured, to which the element substrate and the structure body in which the high-strength fiber of an organic compound or an inorganic compound is impregnated with the organic resin are fixed together.

A method for removing thrombus or other material from a natural or synthetic body vessel or cavity without the need for direct surgical access. The method includes providing a device supplying high pressure fluid to at least one distal orifice, causing high pressure fluid to emanate from the orifice creating at least one fluid jet, and using the fluid jet to break up material in the vessel. The method further includes directing at least one fluid jet at the opening of an exhaust lumen or target incorporated into the device and using the jet to provide a localized negative pressure which entrains material into the jet for break-up. The method optionally includes using the jet to provide stagnation pressure which drives material along the exhaust lumen. The method optionally includes metering the exhaust to match the fluid input or to be greater or less than the input. A positive displacement pump operating at steady or pulsatile flow provides the high pressure saline to the distal end of the catheter.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and / or compounds may be utilized to promote healing, including the formation of blood clots. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and / or compounds from the implantable medical devices.

A device for removing a thrombus or other tissue deposit from the cardiovascular system, natural or synthetic tubule or cavity found in the human body of a patient without the need to surgically access the location of the thrombus or other tissue deposit via a cut-down or other surgical procedure. A flexible metal or high pressure plastic tube conveys an extremely high pressure stream of sterile saline or other physiologic solution to at least one jet at the distal end of the catheter. At least one jet is directed at the opening of a large exhaust lumen or other target. The jet(s) is responsible for providing a localized negative pressure which entrains tissue into the jet from break-up of the debris. This jet(s) can also provide stagnation pressure in the exhaust lumen which drives the tissue or thrombotic debris out of the exhaust lumen. Operation of the device with tip pressure greater than 500 psi provides this device with the entrainment and exhaust characteristics which contribute to its effectiveness. The rate of exhaust of tissue debris is metered to ensure minimal local impact on the vasculature at the site of the thrombus deposit. A fluid metering means, such as a roller pump, controls the rate of exhaust such that it is in balance with the saline input or can be adjusted to be greater or less than the input. A positive displacement pump operating at steady or pulsatile flow provides the high pressure saline to the tip of the catheter.

A retention apparatus for a semi-implantable hearing aid. In one embodiment, the retention apparatus includes a first surface and a second surface. One of the first and second surfaces includes a first portion and a second portion having a rounded transition therebetween for interfacing with a patient's skin. The rounded transition of the interfacing surface of the retention apparatus functions to distribute pressure resulting from the mutual magnetic attraction between an externally located magnet and an implanted magnet to permit increased magnetic forces therebetween and maintenance of a desired separation between an external coil and implanted coil.

A transonic blade is provided that operates in a flow field where flow has a transonic speed or higher in an axial-flow rotating machine and that concurrently achieves a reduction in shock loss and in the local stress of the blade.The transonic blade includes a hub cross-sectional surface joined to a rotating shaft or an outer circumferential side casing of a rotating machine; a tip cross-sectional surface located furthest from the hub cross-sectional surface in a spanwise direction which is a vertical direction of the rotating shaft; a leading edge located on an upstream side; and a trailing edge located on a downstream side. At least a part of a passing working fluid flow has a transonic speed or higher. A portion of a stacking line which is a line connecting together respective gravity centers of cross-sectional surfaces located from the hub cross-sectional surface to the tip cross-sectional surface is located on a downstream side of a stacking center in a flow direction of a working fluid main flow.

A suspension system for suspending a vehicle frame above a plurality of ground-engaging wheels includes a wheel-carrying axle comprising a first end a second end, and a pair of frame bracket assemblies each comprising a resiliently-bushed pivotable connection defining a pivot axis, wherein the frame bracket assemblies are operably coupled to opposite sides of the frame bracket, and wherein the resiliently-bushed pivotable connection comprises a substantially cylindrically-shaped bushing. The suspension system also includes a pair of trailing arms each comprising a first end operably coupled to the first end and the second end of the axle, respectively, and a second end comprising an aperture that receives the bushing of one of the frame bracket assemblies therein, wherein the aperture of the second end of each trailing arm is nonsymmetrical, thereby causing a nonsymmetrical compression of the bushing about the pivot axis. The suspension system also includes embodiments wherein the aperture of the second end of each trailing arm is nonuniform, thereby reducing rotation of the bushing with respect to the trailing arm, wherein a mating surface of each trailing arm operably coupled to the first and second end of the axle comprise a cavity, thereby reducing a localized stress transferred from the trailing arm to the axle, wherein the second end of each trailing arm further comprises a lip extending radially outward from the aperture and at least one engagement surface extending radially outward from the lip and adapted to abut a bushing-removal tool, as well as other improvements.

An assembly for protecting against explosions and explosive devices is formed with aerogels and frangible components. The basic configuration forms a space between an object to be protected by an aerogel having a frangible backing layer. Such assemblies may be mounted on vehicles and structures, and alternatively used as barriers without attachment to other objects. Different geometries for the rear surface of the assemblies enhance the ability of deflecting gas produced by explosions away from objects to be protected. Flowable attenuating media may be introduced into the space behind the aerogel and in gratings placed in the front of assemblies in order to increase blast energy dissipation in intense blast conditions. Armor components may be added to the rear surface to protect against fragments and projectiles. Aerogels, metal foams, and dense ceramic beads may be incorporated to enhance protection against explosively-formed penetrators and other projectiles.

The present invention provides a semiconductor device which is not easily damaged by external local pressure. The present invention further provides a manufacturing method of a highly-reliable semiconductor device, which is not destroyed by external local pressure, with a high yield. A structure body, in which high-strength fiber of an organic compound or an inorganic compound is impregnated with an organic resin, is provided over an element substrate having a semiconductor element formed using a single crystal semiconductor region, and heating and pressure bonding are performed, whereby a semiconductor device is manufactured, to which the element substrate and the structure body in which the high-strength fiber of an organic compound or an inorganic compound is impregnated with the organic resin are fixed together.

The invention relates to a self-propelled drilling method and a nozzle. The self-propelled drilling method is formed by coupling a pulsed jet method, a cavitation jet method and a swirling jet method, wherein, an impeller body arranged in the nozzle can rotate under the impact action of a fluid, a part of forward jet orifices arranged at the head of the nozzle as well as a part of backward jet orifices which are arranged on the nozzle and are opposite to the forward jet orifices can be closed during the rotation process of the impeller body, the fluid is ejected from the other part of the forward jet orifices and the backward jet orifices so as to form jet flow, and the forward jet orifices are alternately closed so as to generate pulsed jet during the rotation process of the impeller body; the fluid entering the nozzle is driven to rotate by the rotating impeller body, and then the rotating fluid is ejected from the jet orifices so as to generate swirling jet; and the central pressure in the nozzle can be reduced by means of rotation of the impeller body so as to form cavitation jet. In the self-propelled drilling method, advantages of the three types of jet flow are integrated so as to greatly improve the drilling efficiency; and the self-propelled drilling method and the nozzle are applicable to drilling holes in a ground layer.

The invention relates to a pulse cavitation multiple jet nozzle, which comprises a nozzle body which is formed into an open end on one end and a jet end with a hollow cylinder on the other end, the open end is used for connecting with a fluid pipe, and the jet end is provided with a plurality of jet orifices; the central position of the jet end is provided with a central jet orifice, and a plurality of lateral jet orifices are arranged around the central jet orifice; the nozzle body is internally provided with an impeller being capable of rotating, a part of the fluid flowing into the nozzle passes through the center of the impeller and the central jet orifice to form continuous straight jet, the other part of the fluid impacts the blades of the impeller to cause the impeller to rotate so as to make flow field on the inlets of the lateral jet orifices around the central jet orifice generate regular disturbance, thus a pulse jet can be formed, vacuole can be produced, a cavitation jet can be formed, and the cavitation jet and the pulse jet are coupled to form a pulse cavitation jet to be ejected from the lateral jet orifices. The invention is simple in structure, and can greatly improve the efficiency of drilling.

A package, and method of manufacturing the same, the package having an attached strap handle for ease in carrying and pouring of the contents. In one embodiment, the package includes a pair of panels separated by a gusseted panel portion. Each end of the strap handle is attached to the package through slits that are formed at the confluence of the gusset panel portion and a respective one of the panels. Seams or seals may be formed to effectively seal the slits and may bond the handles to the package. The handle may additionally include first and second strap handles, and a strap or member spanning between the first and second strap handles.

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and / or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and / or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and / or compounds from the implantable medical devices.

In a fluidic drive for disposition between two components which are movable relative to each other comprising a hollow body with a duct for supplying fluid to, and discharging it from, the hollow body wherein the hollow body consists at least partially of a bellows structure, non-resilient ring elements extend around the hollow body in each of its pleats and a connecting structure extends at least at one side of the hollow body and interconnects the non-resilient ring elements.

The present invention relates to inductively coupled plasma mass spectrometry (ICPMS) in which a collision cell is employed to selectively remove unwanted artefact ions from an ion beam by causing them to interact with a reagent gas. The present invention provides a first evacuated chamber (6) at high vacuum located between an expansion chamber (3) and a second evacuated chamber (20) containing the collision cell (24). The first evacuated chamber (6) includes a first ion optical device (17). The collision cell (24) contains a second ion optical device (25). The provision of the first evacuated chamber (5) reduces the gas load on the collision cell (24), by minimising the residual pressure within the collision cell (24) that is attributable to the gas load from the plasma source (1). This serves to minimise the formation, or re-formation, of unwanted artefact ions in the collision cell (24).

An apparatus and method for fixing a selected graft relative to a selected anatomical portion. An anchor may be provided that may be interconnected with a selected graft portion that is operable to pass through a selected bore and then moved into an operable position to engage a selected portion of the bore to substantially eliminate the possibility of the graft moving in an unselected direction through the bore. In addition, a spacer member may be used to expand a selected portion of the graft to reduce localized stress and may increase ingrowth into a selected bony portion.

Thin amorphous or partially crystalline lithium-containing and conducting sulfide or oxysulfide glass electrode / separator members are prepared from a layer of molten glass or of glass powder. The resulting glass films are formed to lie face-to face against a lithium metal anode or a sodium metal anode and a cathode and to provide for good transport of lithium ions between the electrodes during repeated cycling of the cell and to prevent shorting of the cell by dendrites growing from the lithium metal or sodium metal anode.